Prevention and treatment campaigns are not adequately targeting the particular needs of the 50+ years age group.

Kenya is facing renewed pressure from the international community to urgently address the rising cases of child abuse, ...

Just two months ago, people living with HIV in Kenya were in distress over a crippling shortage of first-line antiretroviral ...

Samuel, who is battling TB, HIV and a mental illness, was arrested, charged with causing disturbance and detained for nine ...

Over the past 20 years we have seen great progress in the HIV response; as of 2024 more than 30 million people were accessing antiretroviral treatment, accounting for more than 76 per cent of all ...

Health Cabinet Secretary Aden Duale on Monday held a high-level meeting with a delegation from UNAIDS, led by Country Director Medhin Tsehaiu, to discuss strengthening Kenya's HIV/AIDS response.During ...

A few years ago, a governor "drove around with us, just pointing at different plots of land, saying 'I want that, I want that'," said Preston Mendenhall, Kenya country head for Rendeavour ...

Bank Al Habib Limited (BAHL) is officially closing its representative office in Kenya, following formal approvals from the central banks of both Pakistan and Kenya. BAHL disclosed the development ...

This rollback in HIV science and programming mirrors the broader erasure of trans people's social, health-care, and legal rights. These occurrences are not haphazard. Instead, they reflect targeted ...

The NCDC described AMR as a ‘silent killer’ deadlier than malaria, tuberculosis (TB), and human immunodeficiency virus (HIV) combined. Dr Jide Idris, Director General, NCDC, said this in an ...

Zimbabwe and Kenya, all racing to develop vaccines and highly effective HIV preventive or management therapy. Such gene sequencing work in Africa is also crucial to help understand how diseases ...

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand in the U.S. GSK plans to bring five new specialty medicines to market ...